title: Folate usage in MTX-treated juvenile idiopathic arthritis (JIA) patients is inconsistent and highly variable.
abstract: Folate supplementation is widely accepted and utilized for the prevention of adverse events in juvenile idiopathic arthritis (JIA) patients who are treated with methotrexate. Despite the widespread use of folate supplementation, there is a lack of convincing evidence to support the role of folate in the enhancement of methotrexate efficacy and the prevention of methotrexate-related adverse events. In order to understand current practices used by experts, we surveyed 214 pediatric rheumatologists around the globe. Seventy-one unique folate supplementation regimens were reported for this study. Results indicated that folate supplementation (either in the form of folic acid or folinic acid) is inconsistent and highly variable within the United States as well as between the United States and other countries. This level of variability is often associated with lack of evidence and emphasizes the need for well-designed clinical trials to support a rational folate supplementation regimen in patients with JIA who are treated with methotrexate.
authors: Department of Pediatric Rheumatology, University of California, Los Angeles, 10833 Le Conte Avenue, MDCC 12-430, Los Angeles, CA 90095, USA. gamarilyo@tlvmc.gov.il
authors: Gil
authors: G
authors: Amarilyo
authors: Department of Pediatric Rheumatology, University of California, Los Angeles, 10833 Le Conte Avenue, MDCC 12-430, Los Angeles, CA 90095, USA. gamarilyo@tlvmc.gov.il
authors: Gil
authors: G
authors: Amarlilyo
authors: Ornella J
authors: OJ
authors: Rullo
authors: Deborah K
authors: DK
authors: McCurdy
authors: Jennifer M P
authors: JM
authors: Woo
authors: Daniel E
authors: DE
authors: Furst
mesh_terms: D000293:Adolescent; D000328:Adult; D001171:Arthritis, Juvenile / Q000188:drug therapy*; D002648:Child; D019587:Dietary Supplements; D005492:Folic Acid / Q000008:administration & dosage*; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage*; D008727:Methotrexate / Q000009:adverse effects*
chemical_list: D005492:Folic Acid; D002955:Leucovorin; D008727:Methotrexate
references: N Engl J Med. 1992 Apr 16;326(16):1043-9
references: 1549149
references: Arthritis Rheum. 2005 Oct;52(10):3030-8
references: 16200612
references: Arthritis Rheum. 1997 Dec;40(12):2226-34
references: 9416861
references: J Pediatr. 1998 May;132(5):901-2
references: 9602213
references: Arthritis Rheum. 1996 Feb;39(2):272-6
references: 8849378
references: Arthritis Rheum. 1990 Jan;33(1):9-18
references: 2405864
references: Arch Dis Child. 2006 Jun;91(6):537-8
references: 16714734
references: J Rheumatol. 1997 Nov;24(11):2230-2
references: 9375889
references: J Rheumatol. 2010 Apr;37(4):870-5
references: 20194449
references: Clin Exp Rheumatol. 1999 Sep-Oct;17(5):625-7
references: 10544851
references: Ann Rheum Dis. 1991 Dec;50(12):913-4
references: 1768158
references: Paediatr Drugs. 2006;8(6):347-56
references: 17154642
references: Arthritis Rheum. 2001 Jul;44(7):1515-24
references: 11465701
references: J Am Coll Nutr. 2007 Oct;26(5):453-5
references: 17914133